New Chimeric Antigen Receptor Design for Solid Tumors
In recent years, chimeric antigen receptor (CAR) T-cell therapy has become popular in immunotherapy, particularly after its tremendous success in the treatment of lineage-restricted hematologic cancers. However, the application of CAR T-cell therapy for solid tumors has not reached its full potentia...
Main Authors: | Yuedi Wang, Feifei Luo, Jiao Yang, Chujun Zhao, Yiwei Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01934/full |
Similar Items
-
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01) -
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
by: Erhao Zhang, et al.
Published: (2018-01-01) -
Chimeric Antigen Receptor-Engineered T Cells in Tumor Immunotherapy: From Bench to Beside
by: Peng WANG
Published: (2017-06-01) -
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01) -
Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2019-04-01)